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Combining Adult Stem Cells and Olfactory
Ensheathing Cells: The Secretome Effect
Nuno A. Silva,1–3 Jeffrey M. Gimble,4 Nuno Sousa,2,3 Rui L. Reis,1,2 and Anto´nio J. Salgado2,3
Adipose-derived adult stem cells (ASCs), bone marrow mesenchymal stem cells (bmMSCs), and human um-
bilical cord perivascular cells (HUCPVCs) tissue have been widely tested for regenerative applications, such as
bone regeneration. Moreover, olfactory ensheathing cells (OECs) show promise in promoting spinal cord injury
(SCI) regeneration. Our group recently proposed the use of a hybrid scaffold targeting both vertebral bone repair
and SCI regeneration. According to this concept, both MSCs and OECs should be in close contact to be influ-
enced by the factors that are involved in secretion. For this reason, here we studied the effects of the OEC
secretome on the metabolic activity and proliferation of ASCs, bmMSCs, and HUCPVCs. The stem cells’ se-
cretome effects on metabolic activity and proliferation of the OECs were also considered. In co-cultures of OECs
with ASCs, bmMSCs, or HUCPVCs, the metabolic activity/viability, proliferation, and total cell numbers were
measured after 2 and 7 days of culture. The results demonstrated that the secretome of OECs has a positive effect
on the metabolic activity and proliferation of MSCs from different origins, especially on ASCs. Furthermore, in
general, the stem cells’ secretome also had a positive effect on the OECs behavior, particularly when ASCs were
in co-culture with OECs. These results suggest that the most suitable combination of cells to be used in our
hybrid scaffold is the OECs with the ASCs. Finally, this work adds new knowledge to the cell therapy field,
bringing new information about paracrine interactions between OECs and distinct mesenchymal stems.
Introduction
Transplantation of cells with regenerative capabilitiesholds great promise for the treatment of several diseases.
However, the properties of the tissue into which the cells are
to be transplanted, as well as the intrinsic properties of the
transplanted cells will significantly influence the success of
the therapy. In spinal cord injury (SCI), the host environment
is particularly important. For instance, after SCI, an environ-
ment of necrosis, edema, inflammation, and degeneration
emerges [1]. This unfavorable host environment will influence
the ability of the transplanted cells to engraft, proliferate,
differentiate, and, thus, to contribute to the repair of the
damaged tissue. Poor engraftment and survival of trans-
planted cells within the injury site remains a major limitation
for cell therapy. The survival of transplanted cells is an es-
sential prerequisite for any successful cell transplantation
approach. However, another fundamental requirement is the
incorporation of the grafted cells into the body of the host.
Therefore, some authors have been studying approaches to
support engraftment and/or survival of implanted cells. For
instance, Chacko et al. studied the effect of hypoxia pretreat-
ment on cell expression of functional proteins that may in-
crease their survival and engraftment after transplantation
[2]. Hydrogels have also been used as vehicles for cell trans-
plantation in order to improve survival [3–5]. For instance,
Johnson et al. reported that fibrin scaffolds can enhance sur-
vival of neural stem/progenitors cells (NSPCs) in a sub-acute
model of SCI [4]. Work from the Shoichet lab shows that a
combination of cyclic-AMP, fibrin, and chitosan channels
greatly enhances the survival of NSPCs after transplantation
in SCI rats [5]. Our group recently proposed the use of a hy-
brid tubular scaffold that comprises a rigid layer (composed
by a blend of starch with polycaprolactone - SPCL), sur-
rounding the hydrogel gellan gum [6]. According to this
concept, the SPCL tubular structure assures mechanical
stability to the entire construct, namely by establishing a
connection to the adjacent vertebral bone [7], while the gellan
gum hydrogel is aimed as a cell encapsulation system to
support axonal regeneration in the injured spinal cord. In
order to improve bone repair, mesenchymal stem cells
(MSCs), such as adipose-derived adult stem cells (ASCs),
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human umbilical cord perivascular cells (HUCPVCs), or bone
marrow MSCs (bmMSCs), can be seeded on the SPCL layer.
Previous studies have demonstrated that these cells have the
capability to undergo osteogenic differentiation and secrete
extracellular matrix (ECM) that is rich in calcium phosphates
(ECM typically found in bone tissues) [8–10]. Alternatively,
cells such as olfactory ensheathing cells (OECs), which are
known to support and guide olfactory axons, secrete several
neurotrophic factors, grow through the glial scar, and pro-
mote motor improvements of SCI rats [11–15], are suitable
candidates to be encapsulated in the hydrogel phase aimed at
fostering axonal regeneration. In this sense, our therapeutic
approach puts in close contact both the MSCs and the OECs,
allowing the secreted factors by these cells to diffuse and in-
teract with each other (see schematic representation on Fig. 1).
For this reason, in this work, we studied the interactions of the
OECs secretome on the proliferation, metabolic activity, and
differentiation of ASCs, HUCPVCs, and bmMSCs, as well as
the effects of the stem cells’ secretome on OECs behavior. The
portmanteau secretome is not often used in literature, but it
was defined as ‘‘the global group of secreted proteins into the
extracellular space by a cell, tissue, organ, or organism, at any
given time and condition through known and unknown se-
cretory mechanisms’’ [16]. In this sense, we expect to find the
best suitable secretome combination, between OECs and
adult stem cells, to be then used in our hybrid scaffold.
Materials and Methods
Cell culture
To evaluate the potential positive or negative effects of the
cell secretome of OECs and adult stem cells, transwell co-
culture experiments were performed. OECs were seeded
(1· 105 cells) on poly-D-lysine cover glass, and adult stem
cells were seeded (4· 104 cells) on the transwell. During the
co-culture period, all conditions (co-cultured and control
cells) were maintained in Dulbecco’s modified Eagle med-
ium supplemented with F12 (DMEM/F12, Gibco) with 10%
of fetal bovine serum (FBS; Gibco) with Bovine Pituitary
Extract (5mg/mL; Gibco), Forskolin (2mg/mL; Sigma), and
1% of antibiotic-antimycotic solution (Sigma) at 37C and 5%
CO2. Cell proliferation, metabolic activity, and differentia-
tion were assessed after 2 and 7 days in culture. Cells were
obtained and expanded as described next:
Olfactory ensheathing cells. Rat OECs were isolated as
previously described [17]. Briefly, on olfactory bulb collec-
tion, all meninges were removed, and the tissue was digested
with 0,125% Collagenase (Sigma) for 20min at 37C. The
digested tissue was mechanically dissociated with a pipette
and then filtrated through a 70 mm cell strainer (BD Falcon).
After centrifugation at 1,000 rpm for 10min, cells were re-
suspended and plated in uncoated wells for 18 h. Then, cells
were plated again into new uncoated wells for 36 h; it is
expected that most of the fibroblasts and astrocytes will at-
tach in the first and second period, respectively. Finally, the
cell suspensions were transferred to poly-D-lysine treated
flasks and cultured in DMEM/F12 (Gibco) with 10% of FBS
(Gibco) and 1% of antibiotic-antimycotic solution (Sigma) at
37C and 5% CO2. OECs were enriched by medium sup-
plementation with Bovine Pituitary Extract (5 mg/mL; Gibco)
and Forskolin (2mg/mL; Sigma).
Human umbilical cord perivascular cells. HUCPVCs were
isolated according to the procedure originally described by
Sarugaser et al. [18]. Pieces of cord were dissected by first
removing the epithelium of the umbilical cord section along
its length to expose the underlying Wharton’s jelly. Each
FIG. 1. Rationality and schematic representation of the study. (A) Both adult stem cells (red cells seeded on the outer layer of
the hybrid scaffolds) and olfactory ensheathing cells (OECs) (green cells encapsulated on the hydrogel) secreted factors that
can affect the biological behavior of each other. (B) Transwell system used to study the effects of cell secretome. (C) Hybrid
scaffold developed and previously characterized [5]. (D) Schematic representation of the scaffold implantation, with the
SPCL layer at the vertebra bone level and the hydrogel at the nervous tissue level. Color images available online at www
.liebertpub.com/scd
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vessel, with its surrounding Wharton’s Jelly matrix, was then
pulled away, after which the ends of each dissected vessel
were tied together with a suture, creating ‘‘loops’’ that were
placed into a solution of 0.5–0.75mg/mL collagenase (Sigma)
with phosphate-buffered saline (PBS; Invitrogen/Gibco).
After 18 h, the loops were removed from the suspension,
which was then diluted with PBS to reduce the viscosity of
the suspension and centrifuged. After the removal of the
supernatant, cells were resuspended in culture media,
a-MEM (Invitrogen/Gibco) supplemented with 10% FBS (In-
vitrogen/Gibco) and 1% antibiotic/antimycotic (Sigma),
counted using a hemocytometer, and platted out in T75 flasks
at a density of 4,000 cells/cm2. The culture medium was
changed every 2/3 days. On confluence, cells were trypsinized
and passaged to new T75 flasks. Using this isolation protocol,
others have previously shown the isolation of a non-
hematopoietic (CD45- , CD34- , SH2+ , SH3+ , Thy-1+ , and
CD44+ ) mesenchymal stem cell population capable of osteo-
genic, chondrogenic, and adipogenic differentiation [10,19].
Bone marrow-derived mesenchymal stem cells. BM-MSCs,
acquired from Lonza, were cultured in a-MEM (Invitrogen/
Gibco) supplemented with 10% FBS and a 1% antibiotic-
antimycotic mixture. The culture medium was changed every
2/3 days. On confluence, cells were trypsinized and passaged
to new T75 flasks. Cells were tested by Lonza for their ability
to differentiate into osteogenic, chondrogenic, and adipogenic
lineages. Moreover, cells are positive for CD105, CD166, CD29,
and CD44 and negative for CD14, CD34, and CD45 [20].
Human adipose-derived adult stem cells. ASCs were isolated
according to a protocol previously described by Dubois et al.
[21]. All protocols were reviewed and approved by the Pen-
nington Biomedical Research Center Institutional Research
Boards (IRB) before the study. Liposuction aspirates from
subcutaneous adipose tissue sites (abdomen, flank, and
thighs) were obtained from female subjects undergoing
elective plastic surgical procedures. Tissues were then di-
gested in a 0.1% collagenase type I (Worthington Biochemical
Corporation) prewarmed to 37C for 60min, after which they
were centrifuged for 5min at 300–500 g at room temperature.
The supernatant, containing mature adipocytes, was aspi-
rated. The pellet was identified as the stromal vascular frac-
tion (SVF). The SVF were suspended and plated immediately
in T225 flasks in Stromal Medium (DMEM/F 12 Ham’s, 10%
fetal bovine serum (Hyclone), 100U penicillin/100mg strep-
tomycin/0.25mg Fungizone) at a density of 0.156mL of tissue
digest/cm2 of surface area for expansion and culture. After
reaching confluence, cells were passaged and kept in stromal
medium. As previously shown, by using this isolation pro-
tocol, we are able to obtain cells capable of differentiating
along multiple mesodermal lineage pathways. Moreover, the
cell surface protein phenotype of ASCs resembles that of
adult stem cells derived from bone marrow stroma [22].
Metabolic activity assay
Cell viability was measured using the CellTiter 96 Aqu-
eous One Solution Cell Proliferation Assay (Promega). This
assay is based on the bioreduction of a tetrazolium compound
(MTS), into a water-soluble brown formazan product. This
conversion is accomplished by NADPH or NADH production
by the dehydrogenase enzymes in metabolically active cells.
Complete culture medium was replaced by standard DMEM/
F12 medium containing MTS in a 5:1 ratio and incubated in a
humidified atmosphere at 37C and 5% CO2. After 3h of in-
cubation, the optic density for triplicates of each sample (n=3)
was measured at 490nm in a microplate reader.
Cell proliferation assessment
The cell proliferation rate was determined using the
5-bromo-2¢-deoxyuridine assay (BrdU; Roche), which quan-
tifies the BrdU incorporation during DNA synthesis in rep-
licating cells. To perform the assay, BrdU was added to the
cell cultures for 24h and after that, the mediumwas removed.
The cells were then fixed and their DNA was denatured with
FixDenat (Roche) in a single step, after which the anti-BrdU
peroxidase antibody (Roche) was added. The immune com-
plexes were detected by the quantification of the substrate
reaction product, measuring the optical density at 370 nm
(reference filter set at 492nm) in a multiplate reader (BioRad).
Immunocytochemistry and phalloidin/DAPI staining
The following primary antibodies were used for the immu-
nocytochemical studies: monoclonal mouse anti-GFAP (Che-
micon) for astrocytes; monoclonal mouse anti-O4 (R&D
Systems) for oligodendrocytes; and polyclonal rabbit anti-p75
(Millipore) for OECs. For all immunohistochemical procedures,
the appropriate controls were obtained by omission of the
relevant primary antibody. Cells on the substrates were fixed
with PBS solution containing 4% PFA for 20min (on glass) or
1h (on the hydrogel) at room temperature and then washed
with PBS. After cell membrane permeation (except for p75 and
O4 antibodies) and blocking by treating with 0.3% Triton X-100
(Sigma) and 10% of FBS solution at room temperature for 1h,
each specific primary antibody solution was added for 1h.
After washing with 0.5% of FBS in PBS, the samples were
exposed to the specific secondary antibody (Invitrogen) for 1h
and then washed with 0.5% FBS. Finally, cell nuclei were
counterstained with 1mg/mL DAPI (Invitrogen) for 1h.
For the phalloidin/DAPI staining, cells were fixed with
4% of paraformaldehyde for 30min at room temperature and
then treated with 0.3% Triton X-100. After PBS washing,
0.1 mg/mL of phalloidin (Sigma) was added to the cells
during 30min. Finally, cell nuclei were counterstained with
DAPI (1mg/mL; Invitrogen) for 10min.
Statistical analysis
All statistical analyses were performed using GraphPad
Prism version 5.00 for Windows (GraphPad Software). Dif-
ferences among groups were assessed by 2-way ANOVA fol-
lowed by a Bonferroni post-hoc test. A P-value of£ 0.05 (95%
confidence level) was set as the criteria for statistical signifi-
cance. All data are presented as mean– standard deviation.
Results
Metabolic activity assessment
The MTS test revealed that the OECs secretome affects the
metabolic activity of MSCs in distinct time-dependent
manners. The mitochondrial activity of stem cells derived
from the adipose tissue in co-culture with OECs was 1.4-fold
higher (P< 0.01) than when ASCs were cultured alone
1234 SILVA ET AL.
(Fig. 2A). However, this difference was only observed after 7
days of incubation. No differences were observed after 2
days of culture. On the contrary, for the stem cells derived
from the bone marrow and from the umbilical cord, it was
possible to observe a significantly higher metabolic activity
when co-cultured with OECs after 2 days of incubation. The
metabolic activity of co-cultured bmMSCs was 1.7-fold
higher (P < 0.05) than bmMSCs in monoculture (Fig. 2B),
while the co-cultured HUCPVCs presented a 2.8-fold higher
(P < 0.001) activity than cells growing in monoculture (Fig.
2C) For these 2 cell populations, no differences were ob-
served between controls and co-cultures after 7 days. More-
over, no detrimental effect of the OECs secretome on the
metabolic activity of all adult stem cells used was observed.
The study of the stem cells’ secretome effects on the met-
abolic activity of OECs revealed that, after 2 days of culture,
each stem cell’s secretome produced different outcomes on
the OECs activity. The metabolic activity of the OECs was
1.3-fold higher (P < 0.01) when co-cultured with ASCs (Fig.
2D) and HUCPVCs (Fig. 2F) than when in monoculture. In
contrast, under the effects of the bmMSCs secretome, the
OECs presented a 2.5-fold lower (P < 0.001) metabolic activ-
ity than the control cells (Fig. 2E). All the effects observed
after 2 days of culture, either positive or negative, were not
observed after 7 days of culture, as the metabolic activity of
OECs was similar in both cells in co-culture and controls.
Proliferation rate evaluation
The BrdU incorporation during DNA synthesis in repli-
cating cells was used to quantify the proliferation rate of the
stem cells and OECs. Each of the stem cells was affected in a
similar way by the OECs secretome. After 2 days of culture,
all the distinct stem cells that were co-cultured together with
the OECs presented significantly higher proliferation rates
than the ones growing in monoculture. Co-cultured ASCs
exhibited a 1.5-folder increase (P < 0.01) with regard to the
proliferation rate than the monoculture cells (Fig. 4A). In
addition, co-cultured bmMSCs and HUCPVCs presented an
approximately 2.5-fold increase (P< 0.001) than monoculture
cells (Fig. 4B, C). No differences in the proliferation rate of
the distinct stem cells were detected after 7 days.
The study of the stem cells’ secretome effect on the pro-
liferation rate of OECs showed that just the secretome of
HUCPVCs significantly influenced the OECs proliferation.
Co-cultured OECs presented a 1.7-fold increase (P < 0.01) of
BrdU incorporation than monocultured OECs (Fig. 3F). This
difference was observed only at the day 2 of co-culture, as
no differences were observed at day 7. OECs growing under
the influence of the ASCs or bmMSCs secretome did not
present significant differences when compared with OECs in
monoculture both after 2 and 7 days (Fig. 3D, E). Finally,
results show that both the stem cells and OECs secretomes
FIG. 2. Metabolic activity of OECs and adult stem cells culture in transwell systems and in monoculture. Metabolic activity
of (A) adipose-derived adult stem cells (ASCs), (B) bone marrow mesenchymal stem cells (bmMSCs), and (C) human
umbilical cord perivascular cells (HUCPVCs) in monoculture or in co-culture with OECs. Metabolic activity of OECs in
monoculture or in co-culture with (D) ASCs, (E) bmMSCs, and (F) HUCPVCs. Values are shown as mean – standard
deviation (n = 3 samples of 2· 104 adult stem cells and 1· 105 OECs/sample, *P < 0.05; **P < 0.01; ***P < 0.001).
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FIG. 3. Proliferation rate of OECs and adult stem cells culture in transwell systems and in monoculture. Proliferation rate of
(A) ASCs, (B) bmMSCs, and (C) HUCPVCs in monoculture or in co-culture with OECs. Proliferation rate of OECs in
monoculture or in co-culture with (D) ASCs, (E) bmMSCs, and (F) HUCPVCs. Values are shown as mean – standard
deviation (n= 3 samples of 2· 104 adult stem cells and 1· 105 OECs/sample, **P < 0.01; ***P < 0.001).
FIG. 4. Immunocytochemistry counting of OECs and adult stem cells culture in transwell systems (gray line) and in
monoculture (black line). Total number of (A) ASCs, (B) bmMSCs, and (C) HUCPVCs in monoculture or in co-culture with
OECs. Total number of p75-positive cells (OECs) in monoculture or in co-culture with (D) ASCs, (E) bmMSCs, and (F)
HUCPVCs. Values are shown as mean – standard deviation (n = 3 samples of 2· 104 adult stem cells and 1· 105 OECs/
sample, *P < 0.05; ***P < 0.001).
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do not negatively influence the proliferation rate of each
other.
Total number of cells
After 2 and 7 days in co-culture, the stem cells and the
OECs were subjected to an immunocytochemistry protocol
in relation to the cell density and the stem cell differentiation.
The proliferation studies revealed that the total number of
ASCs and bmMSCs evolved from similar levels at day 2 to
significantly higher cell densities at day 7, only when cells
were under the influence of the OEC secretome. The number
of co-cultured ASCs was 1.8-fold higher (P < 0.001) than the
monocultured ASCs (Fig. 4A). Moreover, bmMSCs condi-
tioned by the OEC secretome were 1.2-fold more (P< 0.05)
than bmMSCs in monoculture (Fig. 4B). In contrast, it was
possible to observe that the factors produced by the OECs
did not significantly affect the density of HUCPVCs
(Fig. 4C).
The factors produced by the stem cells revealed to have a
positive effect on the OECs. The number of p75-positive cells
(marker for OECs) was similar after 2 days of culture;
however, after 7 days, the density of p75-positive OECs was
significantly higher when these cells were co-cultured with
ASCSs or bmMSCs than in monoculture. The number of
OECs conditioned by the ASCs’ secretome was 2.0-fold
higher (P < 0.05) than OECs growing solo (Fig. 4D). In ad-
dition, OECs conditioned by bmMSCs’ secretome was 1.6-
fold higher than controls (Fig. 4E). This positive effect was
not observed under the HUCPVCs secretome influence; in
this circumstance, OECs did not significantly increase in
number when compared with controls (Fig. 4F).
Finally, immunocytochemistry studies revealed that the
factors secreted by the OECs did not induce the differentia-
tion of the adult stem cells in OECs. The adult stem cells
either in monoculture or in co-culture did not express the
p75, S100, or GFAP biomarker, as no positive staining (green
color) was observed in Fig. 5A–F. Nevertheless, the phalloi-
din/DAPI staining confirmed the results described earlier.
The factors produced by the OECs significantly promoted
proliferation of the ASCSs (Fig. 5D) and bmMSCs (Fig. 5E)
but not the HUCPCVs (Fig. 5F). In addition, immunocyto-
chemistry revealed that the factors secreted by ASCs and
bmMSCs increased the density of OECs (Fig. 5G–J).
Discussion
The use of cells with the capacity to repair or substitute a
damaged tissue holds great promise for the regenerative
medicine field. Due to their sui generis characteristics, such as
FIG. 5. Images of fluorescence microscopy of adult stem cells and OECs either in monoculture or in transwell cultures.
(A–F) The cytoplasm of adult stem cells was stained with the anti-F-actin dye phalloidin and nuclei counterstained with
DAPI. (G–J) The OECs were identified with immunocytochemistry against p75 protein. Color images available online at
www.liebertpub.com/scd
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the ability to differentiate and replace damaged cells, to se-
crete trophic factors, and to be easily obtained from human
patients, adult stem cells are potential candidates for clinical
treatments. In context of SCI, OECs hold particular promise
for promoting regeneration. OECs are responsible for the
continuous growth of new axons into the central nervous
system (CNS) tissue that takes place in the adult olfactory
system [11]. Moreover, several authors previously demon-
strated that OECs have the ability to promote regeneration of
CNS axons both in vitro and in vivo [14,23–25]. However,
most of the data obtained until now suggest that no single
cell therapy will be sufficient to overcome all the biological
complications caused by SCI. For this reason, in the work
presented here, we study the possible positive or detrimental
effects of the secretome of OECs and adult stem cells derived
from the adipose, bone marrow, and umbilical cord tissue.
The results presented here show that the secretome of
OECs exerts a positive effect on the metabolic activity and
proliferation of MSCs from different origins (All results are
summarized in Table 1). However, it is possible to observe
that this effect is higher for the ASCs than for the other stem
cells, namely in proliferation. Moreover, the stem cells se-
cretome also have beneficial effects in the metabolic activity
and proliferation/survival of OECs. Again, the stem cells
from adipose origin have a stronger impact on the OECs
behavior than the other stem cells. In this sense, the most
adequate cell type to be combined with the OECs in future
studies would be the ASCs. It is important to point out that
in future experiments, after the cell seeding (the stem cells on
the SPCL layer, and the OECs on the hydrogel) and after the
scaffold implantation in SCI animal models, the secreted
factors produced by the stem cells will most likely influence
the OECs behavior as well as the nervous cells from the
injured tissue where the OECs are implanted. In this sense,
the MSCs secretome can also be advantageous for the injured
spinal cord site, promoting the growth and regeneration of
damaged tissue. Previous studies demonstrated that the se-
cretome of the stem cells used here have a beneficial effect on
nervous cells. For instance, Ribeiro et al. previously reported
that the secretome of bmMSCs increased the cell viability of
hippocampal cultures as well as the number of neurons in
culture [26]. Moreover, similar results were obtained using the
conditioned medium of HUCPVCs and ASCs in neuronal and
glial cultures [27,28]. To the best of our knowledge, the results
presented here show for the first time the secretome interac-
tions between OECs and ASCs, HUCPVCs, and bmMSCs on
the metabolic activity and proliferation of the cells.
The explanation behind the positive effects of the OECs
secretome on the stem cells behavior may be related with the
ability of OECs to produce several neurotrophic factors. It
was previously reported that OECs are capable of producing
nerve growth factor, brain-derived neurotrophic factor
(BDNF), and glial-derived neurotrophic factor (GDNF) [13].
The higher metabolic activity and proliferation rate pre-
sented by the stem cells may be a consequence of the action
of these factors. Moreover, these results are also in accor-
dance with a previous work in which we demonstrated that
the OEC secretome is able to promote the proliferation of
neural stem cells in either 2D or 3D culture [29].
The stem cells used here are also able to secrete several
factors. For instance, Rehman et al. previously reported that
ASCSs produce basic fibroblast growth factor, vascular en-
dothelial growth factor (VEGF), and transforming growth
factor beta [30]. In addition, previous studies also demon-
strated that bmMSCs and HUCPVCs are capable of secreting
factors such as BDNF, GDNF, VEGF, and granulocyte-
colony stimulating factor [31,32]. These factors secreted by
the stem cells may explain why the OECs in co-culture pre-
sented a higher number of p75-positive cells.
It was only possible to find a single report using a similar
strategy to the one that we used in this work. Wang et al. co-
cultured OECs and ASCs and found out that in this condi-
tion, ASCs were able to differentiate into OECs-like cells [33].
These results contrast with the ones presented here, where
no differentiation was detected for all the stem cells used,
including the ASCs. The possible explanations for this dif-
ference may reside on the substrate where the ASCs were
growing. In Wang’s work, the authors seeded the ASCs on a
collagen scaffold, as they believe that the 3D culture is an
important factor in the ASCs differentiation. We believe that
not only the 3D culture, but also the collagen itself may have
influence on the ASCs differentiation.
Amemori et al. previously demonstrated that the co-
transplantation of OECs and bmMSCs does not have syn-
ergistic effects after SCI in the rat compression model [34].
Interestingly, the only negative effect observed here was
between the OECs and bmMSCs, namely the secretome of
the bone marrow-derived stem cells negatively affected the
metabolic activity of the OECs. This may be one of the rea-
sons for the absence of synergistic effects.
Conclusions
In summary, the results described here add new knowl-
edge in the cell therapy field about the secretome effects be-
tween OECs and MSCs from adipose, bone marrow, and
umbilical cord origins. The results demonstrated that the
most suitable combination of cells to be used in our thera-
peutic concept is the OECs with the ASCs. It should be no-
ticed, however, that in this work we are combining rat
Table 1. Summary of the Secretome Effects Between Olfactory Ensheathing Cells and Adult Stem Cells
ASCs4OECs MSCs4OECs PVCs4OECs
Metabolic activity [ [ [[ YY [[ [
Proliferation rate [[ — [[ — [[ [[
Cell number [ [[ [ [ — —
Culture purity n/a [[ n/a [[ n/a [[
One arrow symbolizes a difference of 1.01- to 1.49-fold, and two arrows symbolize a difference of 1.5-fold or higher on the parameter tested.
The direction of the arrow (up or down) means positive or negative effects, respectively. Lines mean not significantly different. n/a means not
applicable.
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secretome to act in human targets. Therefore, in order to fully
evaluate its translation potential to clinical applications, fur-
ther work will focus on the study of the secretome interac-
tions between MSCs and OECs derived from human sources.
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